Willem Daneels

Miscellaneous
open access

Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen induced exhaustion

Stijn De Munter (UGent) , Juliane Buhl, Laurenz De Cock (UGent) , Alexander Van Parys (UGent) , Willem Daneels (UGent) , Eva Pascal (UGent) , Lucas Deseins (UGent) , Joline Ingels (UGent) , Glenn Goetgeluk (UGent) , Lore Billiet (UGent) , et al.

(2023) BioRxiv.

Add to list

Journal Article
A1
open access

Real-world estimation of first- and second-line treatments for diffuse large B-cell lymphoma using health insurance data : a Belgian population-based study

Willem Daneels (UGent) , Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Fritz Offner (UGent) and Hélène A. Poirel

(2022) FRONTIERS IN ONCOLOGY. 12.

Add to list

Journal Article
A1
open access

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Renate De Smedt (UGent) , Sara T'Sas (UGent) , André Pedro Pinto De Almeida (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2022) HAEMATOLOGICA. 107(6). p.1448-1453

Add to list

Conference Paper
C3
open access

Real world population-based study of treatment-modalities of diffuse large B-cell lymphoma in Belgium : focus on the older population

Willem Daneels (UGent) , Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Fritz Offner (UGent) and A. Poirel Hélène

(2021) 45th Annual Meeting of the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL 2021) Abstract Book. p.32-32

Add to list

Real world application of R‐chop for diffuse large B‐cell lymphoma (DLBCL) in Belgium and its impact on survival

Willem Daneels (UGent) , M. Rosskamp, G. Macq, Estabraq Ismael Saadoon, A. Degeyndt, Fritz Offner (UGent) and H. Antoine‐Poirel

(2021) HEMATOLOGICAL ONCOLOGY. 39(S2). p.431-432

Add to list

Journal Article
A1
open access

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

Tim Pieters (UGent) , Sara T'Sas (UGent) , Stijn Vanhee (UGent) , André Pedro Pinto De Almeida (UGent) , Yasmine Driege (UGent) , Juliette Roels (UGent) , Wouter Van Loocke (UGent) , Willem Daneels (UGent) , Mathijs Baens, Arnaud Marchand, et al.

(2021) JOURNAL OF EXPERIMENTAL MEDICINE. 218(10).

Add to list

Conference Paper
C3
open access

Real world population-based exploration of the pathology subtyping and treatment-modalities of diffuse large B-cell lymphoma in Belgium in relation to survival

Willem Daneels (UGent) , Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Tim De Geyndt, Fritz Offner (UGent) and Hélène Antoine-Poirel

(2020) EHA25 Virtual - The European Hematology Association, Abstracts.

Add to list

Conference Paper
C3
open access

Teaching an old dog new tricks : activity-on-target interferon to treat T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2020) EHA25 Virtual - The European Hematology Association, Abstracts.

Add to list

Real world population-based exploration of the pathology subtyping and treatment-modalities of diffuse large B-cell lymphoma in Belgium in relation to survival

Willem Daneels (UGent) , Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Fritz Offner (UGent) and Hélène Antoine-Poirel

(2020) 35th General Annual Meeting of the Belgian Hematology Society 2020, Abstracts. In Belgian Journal Of Hematology p.13-13

Add to list

Real world population-based exploration of the pathology subtyping and treatment-modalities of diffuse large B-cell lymphoma in Belgium in relation to survival

Willem Daneels (UGent) , Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Fritz Offner (UGent) and Helene A Poirel

(2019) BLOOD. 134(suppl. 1). p.2894-2894

Academic Bibliography

Willem Daneels

Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen induced exhaustion

Real-world estimation of first- and second-line treatments for diffuse large B-cell lymphoma using health insurance data : a Belgian population-based study

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Real world population-based study of treatment-modalities of diffuse large B-cell lymphoma in Belgium : focus on the older population

Real world application of R‐chop for diffuse large B‐cell lymphoma (DLBCL) in Belgium and its impact on survival

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

Real world population-based exploration of the pathology subtyping and treatment-modalities of diffuse large B-cell lymphoma in Belgium in relation to survival

Teaching an old dog new tricks : activity-on-target interferon to treat T-cell acute lymphoblastic leukemia

Real world population-based exploration of the pathology subtyping and treatment-modalities of diffuse large B-cell lymphoma in Belgium in relation to survival

Real world population-based exploration of the pathology subtyping and treatment-modalities of diffuse large B-cell lymphoma in Belgium in relation to survival

Contents

Support

Contact